Transplantation, AutologousLymphoma, Large B-Cell, DiffuseHematopoietic Stem Cell TransplantationStem Cell TransplantationLymphoma, B-CellAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanLymphoma, Non-HodgkinTransplantation, HomologousTransplantation ConditioningTreatment OutcomeSalvage TherapyVincristineAntibodies, Monoclonal, Murine-DerivedCombined Modality TherapyCyclophosphamideLymphoma, FollicularRemission InductionProto-Oncogene Proteins c-bcl-6DoxorubicinPrednisoneHodgkin DiseaseStem CellsDisease-Free SurvivalEtoposideGerminal CenterPrognosisRecurrenceCytarabineRetrospective StudiesMyeloablative AgonistsLymphomaSurvival RateCarmustineSurvival AnalysisHematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft vs Host DiseaseThiotepaChemotherapy-Induced Febrile NeutropeniaBone Marrow PurgingHematologic NeoplasmsLymphoma, T-Cell, PeripheralLymphoma, Mantle-CellWhole-Body IrradiationFatal OutcomeAmyloidosisHematopoietic Stem CellsBoronic AcidsDexamethasoneBusulfanB-LymphocytesPyrazinesFollow-Up StudiesLymphoproliferative DisordersTranslocation, GeneticGraft SurvivalEpstein-Barr Virus InfectionsLymphoma, B-Cell, Marginal ZoneAntineoplastic Agents, AlkylatingCARD Signaling Adaptor ProteinsIfosfamideAntineoplastic AgentsAntigens, CD34AutograftsThalidomideLiver TransplantationTime FactorsInduction ChemotherapyMesenchymal Stem Cell TransplantationPodophyllotoxinGranulocyte Colony-Stimulating FactorLeukapheresisImmunohistochemistryNeoplasm, ResidualTransplantation ChimeraMaintenance ChemotherapyTissue DonorsLeukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationCell TransplantationAntibodies, MonoclonalMitoxantroneKidney TransplantationNeoplasms, Second PrimaryEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsMyelodysplastic SyndromesCell Line, TumorIdarubicinCisplatinLeukemia, Plasma CellNeoplasm Recurrence, LocalProspective StudiesGene Expression ProfilingInfusions, SpinalTumor Markers, BiologicalImmunophenotyping